Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Lifecycle Approach to Analytical Methods for Drug Products: Incorporating QbD Concepts into Method Development, Validation, Verification and Transfer

16 - 17 July 2015, Boston, United States


Introduction
Course Description:

This highly interactive course is designed to provide participants with a lifecycle approach to developing and validating analytical methods, including elements aligned with QbD concepts. Some of the key aspects of the seminar include:

Learning how to apply QbD concepts to analytical methods
Discussing the types of methods required for different drug products
Understanding the types of impurities which must be addressed for drug products
Discovering how a lifecycle approach can link method development, validation, verification and transfer
Learning how ATP (Analytical Target Profile) can drive the lifecycle approach
Determining the importance of linking method uncertainty to specifications
Using a method feedback loop to facilitate method improvement
This approach will be linked with current compendial requirements. There will be opportunities for questions and interaction throughout the course as well.

Learning Objectives:

Understand the lifecycle approach to method development and validation
Understand the different methods required for various drug products and the types of impurities which must be addressed
Identify an ATP for methods being developed
Use an IQ/OQ/PQ approach to method qualification
Develop appropriate protocols for method transfer
Comply with compendial requirements with greater success and fewer resources

Who Will Benefit:

This seminar on QbD concepts in method development will prove highly beneficial to professionals working in pharmaceutical (human and veterinary), generic or OTC companies or contract research organizations who are responsible for development, validation, verification or transfer of analytical methods.

Chemists (Research, Quality Control, CRO)
Regulatory Affairs/CMC Personnel
Laboratory Managers and Staff
Analysts
QA/QC Managers and Personnel
Speakers
  • Gregory P. Martin Gregory P. Martin is president of Complectors Consulting which provides consulting and training in the area of pharmaceutical analytical chemistry. Mr. Martin has over 25 years’ experience in the pharmaceutical industry and was director of pharmaceutical analytical chemistry (R&D) for a major pharma company for a number of years. In addition, he has volunteered for the USP (U.S. Pharmacopeial Convention) for over 10 years, and currently serves as Vice Chair of the General Chapters – Physical Analysis Expert Committee. He also serves on expert panels on validation and verification, weights and balances, residual solvents and use of enzymes for dissolution testing of gelatin capsules.

    He has particular interest in QbD/lean approaches to dissolution testing, impurity methods, method lifecycle (development/validation/transfer) and instrument qualification, and is passionate about using good science and sound logic to achieve high quality results, consistent with cGMPs, while minimizing resources. He is also past chair of the AAPS in vitro release and dissolution testing focus group. Mr. Martin is author of several papers in the areas of dissolution and analytical method validation., United States

Venue
TBD

TBD, Boston, Boston, 2108, United States

Organised by
ComplianceOnline
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*